INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 179 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $256,000 | +8.5% | 1,557 | -6.0% | 0.01% | +62.5% |
| Q2 2016 | $236,000 | +15.1% | 1,657 | +3.6% | 0.01% | 0.0% |
| Q1 2016 | $205,000 | -62.7% | 1,599 | -56.6% | 0.01% | -27.3% |
| Q4 2015 | $550,000 | -38.5% | 3,685 | -0.5% | 0.01% | -35.3% |
| Q2 2015 | $894,000 | +7.2% | 3,702 | +25.2% | 0.02% | +6.2% |
| Q1 2015 | $834,000 | +80.9% | 2,958 | 0.0% | 0.02% | +77.8% |
| Q4 2014 | $461,000 | -27.3% | 2,958 | +10.5% | 0.01% | -30.8% |
| Q3 2014 | $634,000 | -11.6% | 2,677 | -11.1% | 0.01% | -7.1% |
| Q2 2014 | $717,000 | – | 3,012 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |